Repair of rabbit segmental defects with the thrombin peptide, TP508
- PMID:15304284
- DOI: 10.1016/j.orthres.2004.03.009
Repair of rabbit segmental defects with the thrombin peptide, TP508
Abstract
The synthetic peptide, TP508 (Chrysalin), was delivered to rabbit segmental bone defects in biodegradable controlled-release PLGA microspheres to determine its potential efficacy for enhancing healing of non-critically and critically sized segmental defects. Non-critically sized radial defects were created in the forelimbs of New Zealand White rabbits, which were randomized into three treatment groups receiving 10, 50 and 100 microg doses of TP508 in the right radius and control microspheres (without TP508) in the left radius. Torsional testing of the radii at six weeks showed a significant increase in ultimate torque, failure torque, ultimate energy, failure energy, and stiffness when treated with TP508 compared to controls (p<0.01 for all measures). Thus, TP508 appeared to enhance or accelerate bone growth in these defects. In a second set of experiments, critically sized ulnar defects were created in the forelimbs of New Zealand White rabbits, which were randomized into two groups with each rabbit receiving microspheres with 100 or 200 microg of TP508 into the right ulnar defect and control microspheres (without TP508) alone into the left ulnar defect. Bone healing was evaluated with plain radiographs, synchrotron-based microtomography, and mechanical testing. Radiographs of the rabbit limbs scored by three blinded, independent reviewers demonstrated a significantly higher degree of healing when treated with TP508 than their untreated control limbs (p<0.05). Three-dimensional synchrotron tomography of a limited number of samples showed that the new bone in TP508-treated samples had a less porous surface appearance and open marrow spaces, suggesting progression of bone remodeling. Torsional testing of the ulnae at nine weeks showed a significant increase in maximum torque and failure energy when treated with TP508 compared to controls (p<0.01 for both measures). These results suggest that TP508 in a controlled release delivery vehicle has the potential to enhance healing of segmental defects in both critically and non-critically sized defects.
Similar articles
- Bone formation is enhanced by thrombin-related peptide TP508 during distraction osteogenesis.Li G, Ryaby JT, Carney DH, Wang H.Li G, et al.J Orthop Res. 2005 Jan;23(1):196-202. doi: 10.1016/j.orthres.2004.05.006.J Orthop Res. 2005.PMID:15607893
- Effect of thrombin peptide 508 (TP508) on bone healing during distraction osteogenesis in rabbit tibia.Amir LR, Li G, Schoenmaker T, Everts V, Bronckers AL.Amir LR, et al.Cell Tissue Res. 2007 Oct;330(1):35-44. doi: 10.1007/s00441-007-0448-9. Epub 2007 Jul 17.Cell Tissue Res. 2007.PMID:17636332Free PMC article.
- Local injection of thrombin-related peptide (TP508) in PPF/PLGA microparticles-enhanced bone formation during distraction osteogenesis.Wang Y, Wan C, Szöke G, Ryaby JT, Li G.Wang Y, et al.J Orthop Res. 2008 Apr;26(4):539-46. doi: 10.1002/jor.20495.J Orthop Res. 2008.PMID:17960653
- Thrombin peptide TP508 stimulates cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues.Ryaby JT, Sheller MR, Levine BP, Bramlet DG, Ladd AL, Carney DH.Ryaby JT, et al.J Bone Joint Surg Am. 2006 Nov;88 Suppl 3:132-9. doi: 10.2106/JBJS.F.00892.J Bone Joint Surg Am. 2006.PMID:17079379Review.
- Thrombin peptide, TP508, stimulates angiogenic responses in animal models of dermal wound healing, in chick chorioallantoic membranes, and in cultured human aortic and microvascular endothelial cells.Norfleet AM, Bergmann JS, Carney DH.Norfleet AM, et al.Gen Pharmacol. 2000 Nov;35(5):249-54. doi: 10.1016/s0306-3623(01)00118-5.Gen Pharmacol. 2000.PMID:11888680Review.
Cited by
- Peptide-Based Biomaterials for Bone and Cartilage Regeneration.Kapat K, Kumbhakarn S, Sable R, Gondane P, Takle S, Maity P.Kapat K, et al.Biomedicines. 2024 Jan 29;12(2):313. doi: 10.3390/biomedicines12020313.Biomedicines. 2024.PMID:38397915Free PMC article.Review.
- Development of an experimental model of infected bone void in the ulna of rabbits.Lemos Azi M, Kfuri Junior M, Martinez R, Salata LA, Paccola CA.Lemos Azi M, et al.Acta Ortop Bras. 2012;20(3):136-8. doi: 10.1590/S1413-78522012000300002.Acta Ortop Bras. 2012.PMID:24453593Free PMC article.
- Systemic administration of thrombin peptide TP508 enhances VEGF-stimulated angiogenesis and attenuates effects of chronic hypoxia.Olszewska-Pazdrak B, Carney DH.Olszewska-Pazdrak B, et al.J Vasc Res. 2013;50(3):186-96. doi: 10.1159/000348250. Epub 2013 Apr 16.J Vasc Res. 2013.PMID:23594718Free PMC article.
- Novel regenerative peptide TP508 mitigates radiation-induced gastrointestinal damage by activating stem cells and preserving crypt integrity.Kantara C, Moya SM, Houchen CW, Umar S, Ullrich RL, Singh P, Carney DH.Kantara C, et al.Lab Invest. 2015 Nov;95(11):1222-33. doi: 10.1038/labinvest.2015.103. Epub 2015 Aug 17.Lab Invest. 2015.PMID:26280221Free PMC article.
- Nuclear Countermeasure Activity of TP508 Linked to Restoration of Endothelial Function and Acceleration of DNA Repair.Olszewska-Pazdrak B, McVicar SD, Rayavara K, Moya SM, Kantara C, Gammarano C, Olszewska P, Fuller GM, Sower LE, Carney DH.Olszewska-Pazdrak B, et al.Radiat Res. 2016 Aug;186(2):162-74. doi: 10.1667/RR14409.1. Epub 2016 Jul 7.Radiat Res. 2016.PMID:27388041Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources